Experience of continuous subcutaneous insulin infusion in the outpatient management of diabetic teenagers

Diabet Med. 1986 Jan;3(1):82-4. doi: 10.1111/j.1464-5491.1986.tb00714.x.


Of forty-five adolescent diabetic patients offered continuous subcutaneous insulin infusion (CSII) as part of a large feasibility study, 13 (28.9%) initially chose the treatment, but only 4 out of 11 who actually started CSII continued for one year (64% discontinuation rate). In contrast 30.4% of adults approached chose CSII, and 32% had discontinued after one year. Improvement in glycaemic control was poor, and clinical problems were more common in pump-treated teenagers than in adults. CSII does not appear to be a therapeutic solution for adolescents having difficult management problems.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Blood Glucose / analysis
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Female
  • Humans
  • Insulin / administration & dosage
  • Insulin Infusion Systems*
  • Male
  • Outpatients
  • Patient Compliance


  • Blood Glucose
  • Insulin